Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2020
Reporting Period: Announcement of scheduled conference call to report 2019 Fourth Quarter and Full Year Financial Results.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notification of an upcoming earnings announcement.
Material Changes
No material financial changes are detailed in this filing. The document announces the scheduling of a conference call to discuss prior period results.
Guidance, Outlook, and Management Commentary
Management Action: The Company issued a press release on February 27, 2020, announcing a conference call to report 2019 Fourth Quarter and Full Year Financial Results.
Regulatory Note: The information disclosed under Item 7.01 (Regulation FD Disclosure) and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the date and time of the scheduled conference call for 2019 Fourth Quarter and Full Year results.
- Review the full text of the press release (Exhibit 99.1) for any additional details not included in the 8-K summary.
- Confirm the Company's status as an emerging growth company (indicated as yes in the filing).
- Monitor subsequent filings (e.g., 10-K or 10-Q) for the actual financial data referenced in this announcement.